Reduced High-Frequency Hearing for Speech Perception
Trial Summary
What is the purpose of this trial?
This study examines the effects of low-pass filtering speech on speech perception.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment for Reduced High-Frequency Hearing for Speech Perception?
Research suggests that hearing in the extended high frequencies (above 8 kHz) helps with understanding speech in noisy environments. Although people with high-frequency hearing loss might have normal hearing tests, they can still struggle with speech perception, indicating that improving high-frequency hearing could enhance speech understanding.12345
How does the treatment for reduced high-frequency hearing for speech perception differ from other treatments?
This treatment focuses on the extended high frequencies (EHF) above 8 kHz, which are often overlooked but play a crucial role in speech perception, especially in noisy environments. Unlike conventional treatments that may not address these frequencies, this approach aims to enhance speech understanding by targeting EHF, potentially offering early detection and prevention of hearing loss.26789
Eligibility Criteria
This trial is for people who have normal hearing within the range of 250-8000 Hz and are native speakers of American English. It's not suitable for those with any level of hearing loss or non-native speakers of American English.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo speech perception testing with low-pass filtered speech
Follow-up
Participants are monitored for any immediate effects post-testing
Treatment Details
Interventions
- Reduced extended high-frequency audibility
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brian Monson
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator